Reader for Molecular Informatics
Associate Director Computational ADME and Safety (Clinical Pharmacology & Safety Sciences/Data Science and Artificial Intelligence - CPSS/DSAI) at AstraZeneca Cambridge
Co-founder of Healx Ltd.
Co-founder of PharmEnable Ltd.
- Committed to developing new life science data analysis methods (AI/ML/data science) and their application, primarily related to chemical biology, drug discovery and in silico toxicology
- Expertise comprises data ranging from chemical structure and gene expression data to phenotypic readouts and preclinical information, applied to both efficacy- and safety/tox-related questions
- Collaborating with academic research groups, as well as pharmaceutical, chemical, and consumer goods companies (Eli Lilly, AstraZeneca, GSK, BASF, Johnson&Johnson/Janssen, Unilever, ...)
- Co-founder/founding CTO and current SAB member of Healx Ltd. (data-driven drug repurposing for rare diseases, and beyond); co-founder of PharmEnable Ltd.; SAB member of Lhasa Ltd. (toxicology and metabolism prediction) and Cresset Ltd.
- Coordinator of the Computational & In Silico Toxicology Specialty Section of the British Toxicology Society (BTS)
- Steering Committee Member of the Cambridge Alliance on Medicines Safety (CAMS)
- Currently leading a group of ca. 15 PhD students, postdocs, project students and visitors at the Centre for Molecular Informatics at the University of Cambridge, https://www-cmi.ch.cam.ac.uk/centre-molecular-informatics
Publications
SYSTEMS GENOMICS OF ULCERATIVE COLITIS: COMBINING GWAS, SIGNALLING AND TRANSCRIPTIONAL NETWORKS TO UNCOVER NOVEL PATHOGENIC PATHWAYS
– GASTROENTEROLOGY
(2019)
156,
S605
OP10 Systems genomics of ulcerative colitis: combining GWAS and signalling networks for patient stratification and individualised drug targeting in ulcerative colitis
– Journal of Crohn's and Colitis
(2019)
13,
S6
(DOI: 10.1093/ecco-jcc/jjy222.009)
P011 Signalling and transcriptional network propagation uncovers novel ulcerative colitis pathogenetic pathways from single-nucleotide polymorphisms
– Journal of Crohn's and Colitis
(2019)
13,
S091
(DOI: 10.1093/ecco-jcc/jjy222.135)
Sulfated Ceria Catalyzed Synthesis of Imidazopyridines and Their Implementation as DNA Minor Groove Binders.
– Chem Biodivers
(2019)
16,
e1800435
(DOI: 10.1002/cbdv.201800435)
Correction to: Concordance analysis of microarray studies identifies representative gene expression changes in Parkinson's disease: a comparison of 33 human and animal studies.
– BMC neurology
(2019)
19,
16
(DOI: 10.1186/s12883-019-1240-7)
Characterizing ABC-transporter substrate-likeness using a clean-slate genetic background
– Frontiers in pharmacology
(2019)
10,
448
(DOI: 10.3389/fphar.2019.00448)
Prediction of UGT-mediated Metabolism Using the Manually Curated MetaQSAR Database.
– ACS medicinal chemistry letters
(2019)
10,
633
Maximizing gain in high-throughput screening using conformal prediction
– J Cheminform
(2018)
10,
7
(DOI: 10.1186/s13321-018-0260-4)
Systemic neurotransmitter responses to clinically approved and experimental neuropsychiatric drugs
– Nature communications
(2018)
9,
4699
(DOI: 10.1038/s41467-018-07239-1)
Discovery of a non-toxic [1,2,4]triazolo[1,5-a]pyrimidin-7-one (WS-10) that modulates ABCB1-mediated multidrug resistance (MDR).
– Bioorganic and Medicinal Chemistry
(2018)
26,
5974
(DOI: 10.1016/j.bmc.2018.10.027)
- <
- 2 of 31